NCT00499928View on ClinicalTrials.gov

A Study To Investigate The Metabolism And Excretion Of 14C SB-751689 Given To Healthy Males And Postmenopausal Women

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions

Osteoporosis

Interventions

DRUG

SB-751689

Trial Locations (1)

53704

GSK Investigational Site, Madison

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY